Clinical Trial Update: Ranibizumab Plus Indomethacin [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Ranibizumab in combination with Indomethacin for macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Macular Edema | Phase 4 | Status: COMPLETED